Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2026)

Neuronetics (STIM) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $125.4 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $125.4 million, down 11.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $547.1 million (up 20.56% YoY), and the FY2025 annual result was $141.6 million, changed 0.46% from the prior year.
• Liabilities and Shareholders Equity fell to $125.4 million in Q1 2026 per STIM's latest filing, from $141.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $145.5 million in Q3 2025 and troughed at $74.1 million in Q3 2024.
• A 5-year average of $118.0 million and a median of $119.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity decreased 22.01% in 2023, then jumped 96.26% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $116.9 million in 2022, then decreased by 0.9% to $115.8 million in 2023, then advanced by 21.65% to $140.9 million in 2024, then rose by 0.46% to $141.6 million in 2025, then retreated by 11.38% to $125.4 million in 2026.
• Business Quant data shows STIM's Liabilities and Shareholders Equity at $125.4 million in Q1 2026, $141.6 million in Q4 2025, and $145.5 million in Q3 2025.